曹博
Lv5
1250 积分
2021-09-15 加入
-
Biomarkers Predictive of Long-Term Outcome After Ischemic Stroke: A Meta-Analysis
2天前
已完结
-
Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function
5天前
已完结
-
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
22天前
已完结
-
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
23天前
已完结
-
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
23天前
已完结
-
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
1个月前
已完结
-
MUC1: An emerging target in cancer treatment and diagnosis
1个月前
已完结
-
Recombinant bispecific antibodies for cellular cancer immunotherapy
2个月前
已关闭
-
CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma
2个月前
已完结
-
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach
4个月前
已完结